After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?
After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?

After a miserable debut on stock exchanges, will October 2021 business update propel the stock of Paytm?

The growth momentum in gross merchandise value (GMV) continued in October 2021, driven by festive season spending as well as an increase in the number of merchants & consumers

DSIJ Intelligence-3 Article rating: 4.0

The lending business continued to show very strong growth as a result of the rapid scale-up of all of company’s lending products, including postpaid, consumer loans, and merchant loans.

Stock to watch out on Monday: Bharti Airtel announces revised mobile tariffs
Stock to watch out on Monday: Bharti Airtel announces revised mobile tariffs

Stock to watch out on Monday: Bharti Airtel announces revised mobile tariffs

Accordingly, its new tariffs as indicated below will come into effect from November 26, 2021.  

DSIJ Intelligence-3 Article rating: 5.0

The company has always maintained that the mobile average revenue per user (ARPU) needs to be at Rs 200 and ultimately at Rs 300, so as to provide a reasonable return on capital that allows for a financially healthy business model.   

Reliance and Saudi Aramco mutually call off proposed O2C deal; what should be your next course of action
Reliance and Saudi Aramco mutually call off proposed O2C deal; what should be your next course of action

Reliance and Saudi Aramco mutually call off proposed O2C deal; what should be your next course of action

RIL shall continue to be Saudi Aramco’s preferred partner for investments in the private sector in India and will collaborate with Saudi Aramco & SABIC for investments in Saudi Arabia. 

DSIJ Intelligence-3 Article rating: 3.8

On a weekly basis the stock has plunged 4.62 per cent. The level of Rs 2450 is an important support level for the stock.

Know why Laurus Labs should be on watchlist on Monday!
Know why Laurus Labs should be on watchlist on Monday!

Know why Laurus Labs should be on watchlist on Monday!

The stock of Laurus Labs was seen outperforming the benchmark indices during the week as it gained

DSIJ Intelligence-3 Article rating: 4.0

Interestingly, the stock formed an inside bar on the weekly chart with open=low; hence, the high and low remains a crucial level for the stock in the near term. Meanwhile, the stock is seen trading below its 50-week EMA and also, below the 61.8 per cent retracement level.   

Biocon Biologics and Viatris to offer insulin glargine injection at a discounted price
Biocon Biologics and Viatris to offer insulin glargine injection at a discounted price

Biocon Biologics and Viatris to offer insulin glargine injection at a discounted price

Members can save up to 80 per cent off the cash price of comparable long-acting insulins purchased at Walgreens

DSIJ Intelligence Article rating: 5.0

Biocon Biologics Ltd, a subsidiary of Biocon Ltd, and Viatris Inc confirm that Insulin Glargine injection will be offered through the Walgreens Prescription Savings Club, saving members up to 80 per cent off the cash price of comparable long-acting insulins purchased at Walgreens. 

Stocks below Rs 100: Manugraph zooms over 30 per cent and hits fresh 52-week high, becomes weekly standout performer
Stocks below Rs 100: Manugraph zooms over 30 per cent and hits fresh 52-week high, becomes weekly standout performer

Stocks below Rs 100: Manugraph zooms over 30 per cent and hits fresh 52-week high, becomes weekly standout performer

And interestingly, when the equities are in a risk-off mood, market participants are pushed on the back foot as their vision is blurred by signs of worry.   

DSIJ Intelligence-3 Article rating: 4.0

Amidst all this, these stocks that were seen trading below Rs 100 have delivered a standout performance. So, here are the top gainers from the list of the stocks that are listed below Rs 100.   

RSS
First22522253225422552257225922602261Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR